Please Wait.....
Report
North America Infertility Diagnostics Devices Market Report and Forecast 2024-2032
Market Report I 2024-06-26 I 120 Pages I EMR Inc.
North America Infertility Diagnostics Devices Market Report and Forecast 2024-2032
North America Infertility Diagnostics Devices Market Outlook
The global infertility diagnostics devices market size is expected to grow at a CAGR of 8.80% during the forecast period of 2024-2032, with North America holding a significant market share. The market is driven by the rising prevalence of infertility along with advancements in diagnostic technologies.
Key Takeaways
- In November 2023 , Femasys Inc., secured an upfront investment of USD 6.85 million from PharmaCyte Biotech. The financing will support the commercialization of Femasys infertility-related products, including FemVue, which can help to check tubal infertility or blocked tubes in women. The increased access to such innovative diagnostic devices is likely to augment North America infertility diagnostics devices market share in the forecast years.
- Infertility is a common problem in the United States, with around 11% of women and 9% of men affected by this condition in their reproductive age. Rising infertility burden is likely to elevate market value in the forecast period.
- Intensive research efforts associated with infertility and its treatments are resulting in the development of advanced testing methods. This is are anticipated to boost market growth. In June 2023 , researchers at the University of Alberta discovered two unique protein biomarkers that have the potential to provide a non-invasive diagnostic test for men.
North America Infertility Diagnostics Devices Market Analysis
Infertility can be defined as a condition that impairs the body's ability to reproduce. It can be caused due to issues with the reproductive system of either the male or female partner. In women, the most common cause of infertility includes irregular ovulation, obstructed fallopian tubes, and endometriosis whereas in men, sperm disorders are the common cause of infertility issues. Factors such as lifestyle changes, delayed childbearing, and rising incidence of conditions affecting fertility are contributing to the growing cases of infertility in the region. Heightened patient awareness surrounding infertility along with the reduced stigma attached to seeking treatments for the condition are expected to significantly drive the North America infertility diagnostics devices market demand in coming years.
Rising healthcare expenditure and insurance coverage for infertility treatments in North America are positively influencing the market landscape. Moreover, the increased prevalence of infertility issues in the region directly impacts the demand for infertility diagnostic services and devices. Recent data suggests that infertility is a common problem in the United States, with around 11% of women and 9% of men of child-bearing age affected by this condition. This sharp increase in infertility burden is likely to elevate market value in the forecast period.
The rising investment in the infertility diagnostics sector to address the growing demand for advanced diagnostic solutions is expected to fuel North America infertility diagnostics devices market growth. In November 2023 , Femasys Inc., a United States-based biomedical company, secured an upfront investment of USD 6.85 million from PharmaCyte Biotech (a biotechnology company headquartered in the United States). The financing will support the commercialization of Femasys infertility-related products, FemaSeed and FemVue, as well as the development of a broad portfolio of other products. FemVue, the first FDA-cleared diagnostic device for fallopian tube assessment, can help to check for tubal infertility or blocked tubes in women. The increased access to such innovative diagnostic devices is likely to augment market size in the region.
Intensive research efforts associated with infertility and its treatments are resulting in the development of advanced testing methods, which are anticipated to significantly boost North America infertility diagnostics devices market value. In June 2023 , a team of researchers at the University of Alberta (a public research university in Canada) discovered two proteins that are only found in viable sperms. These unique protein biomarkers have the potential to provide men with a non-invasive diagnostic test that can offer insights into whether in vitro fertilization can work in certain patients. The development of such innovative diagnostic tests with the ability to predict the success rate of surgery in infertile men is expected to accelerate market growth in coming years.
North America Infertility Diagnostics Devices Market Segmentation??
The report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product
- Equipment
- Media & Consumables
- Accessories
Market Breakup by Procedure
- In Vitro Fertilization
- Intracytoplasmic Sperm Injection
- Artificial Insemination
- Fertility Surgeries
- Others
Market Breakup by Patient Type
- Female
- Male
Market Breakup by Type
- Sperm Separation Devices
- Ovum Aspiration Pump
- Sperm Analyzer Systems
- Micromanipulator Systems
- Incubators
- Cryosystems
- Imaging Systems
- Microscope
- Others
Market Breakup by End User
- Hospitals & Surgical Clinics
- Cryobanks
- Research Institutes
- Others
Market Breakup by Countries
- United States of America
- Canada
North America Infertility Diagnostics Devices Market: Competitor Landscape
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Cook Group
- Vitrolife
- Thermo Fisher Scientific
- Hamilton Thorne LTD
- Esco Micro Pte Ltd
- Genea Limited
- IVFtech APS
- FUJIFILM Irvine Scientific
- The Baker Company Inc.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
FAQs
- What is the North America infertility diagnostics devices market forecast outlook for 2024-2032?
The North America infertility diagnostics devices market is expected to be driven by the rising demand for the global infertility diagnostics devices market, which is anticipated to grow at a CAGR of 8.80% during the forecast period of 2024-2032, driven by the rising prevalence of infertility.
- What are the major factors aiding the North America infertility diagnostics devices market demand?
Technological advancements in infertility diagnostics and the rising healthcare expenditure are fuelling the demand for the market.
- What are the major North America infertility diagnostics devices market trends?
One of the significant trends in the market is rising investment in the infertility diagnostics sector. In November 2023, Femasys Inc. secured an upfront investment of USD 6.85 million from PharmaCyte Biotech. The financing will support the commercialization of Femasys infertility-related products, including FemVue, which can help to check tubal infertility or blocked tubes in women.
- What is the market segmentation based on the product?
Based on the product, the market is segmented into equipment, media, consumables, and accessories.
- What are the various procedures available in the market?
Procedures available in the market include in vitro fertilization, intracytoplasmic sperm injection, artificial insemination, and fertility surgeries, among others.
- What is the market breakup by patient type?
By patient type, the market is divided into female and male.
- What is the market segmentation based on the type?
The market breakup by type includes sperm separation devices, ovum aspiration pumps, sperm analyzer systems, micromanipulator systems, incubators, cryosystems, imaging systems, and microscopes, among others.
- What are the major end users of infertility diagnostics devices?
End users include hospitals, surgical clinics, cryobanks, and research institutes, among others.
- What is the market segmentation by countries?
The market segmentation by countries includes the United States of America and Canada.
- Who are the key players involved in the North America infertility diagnostics devices market?
The key players in the market are Cook Group, Vitrolife, Thermo Fisher Scientific, Hamilton Thorne LTD, Esco Micro Pte Ltd, Genea Limited, IVFtech APS, FUJIFILM Irvine Scientific, and The Baker Company Inc.
Meta description
The North America infertility diagnostics devices market is poised for growth, driven by the expansion of the global infertility diagnostics devices market, which is projected to grow at a CAGR of 8.80% during the forecast period of 2024-2032.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 North America Infertility Diagnostics Devices Market Overview
3.1 North America Infertility Diagnostics Devices Market Historical Value (2017-2023)
3.2 North America Infertility Diagnostics Devices Market Forecast Value (2024-2032)
4 North America Infertility Diagnostics Devices Market Landscape*
4.1 North America Infertility Diagnostics Devices: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 North America Infertility Diagnostics Devices: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Procedure
5 North America Infertility Diagnostics Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter's Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 North America Infertility Diagnostics Devices Market Segmentation (2017-2032)
6.1 North America Infertility Diagnostics Devices Market (2017-2032) by Product
6.1.1 Market Overview
6.1.2 Equipment
6.1.3 Media & Consumables
6.1.4 Accessories
6.2 North America Infertility Diagnostics Devices Market (2017-2032) by Procedure
6.2.1 Market Overview
6.2.2 In Vitro Fertilization
6.2.3 Intracytoplasmic Sperm Injection
6.2.4 Artificial Insemination
6.2.5 Fertility Surgeries
6.2.6 Others
6.3 North America Infertility Diagnostics Devices Market (2017-2032) by Patient Type
6.3.1 Market Overview
6.3.2 Female
6.3.3 Male
6.4 North America Infertility Diagnostics Devices Market (2017-2032) by Type
6.4.1 Market Overview
6.4.2 Sperm Separation Devices
6.4.3 Ovum Aspiration Pumps
6.4.4 Sperm Analyzer Systems
6.4.5 Micromanipulator Systems
6.4.6 Incubators
6.4.7 Cryosystems
6.4.8 Imaging Systems
6.4.9 Microscope
6.4.10 Others
6.5 North America Infertility Diagnostics Devices Market (2017-2032) by End User
6.5.1 Market Overview
6.5.2 Hospitals & Surgical Clinics
6.5.3 Cryobanks
6.5.4 Research Institutes
6.5.5 Others
6.6 North America Infertility Diagnostics Devices Market (2017-2032) by Countries
6.6.1 Market Overview
6.6.2 United States of America
6.6.3 Canada
7 United States of America Infertility Diagnostics Devices Market (2017-2032)
7.1 United State of America Infertility Diagnostics Devices Market (2017-2032) by Product
7.1.1 Market Overview
7.1.2 Equipment
7.1.3 Media & Consumables
7.1.4 Accessories
7.2 United State of America Infertility Diagnostics Devices Market (2017-2032) by Procedure
7.2.1 Market Overview
7.2.2 In Vitro Fertilization
7.2.3 Intracytoplasmic Sperm Injection
7.2.4 Artificial Insemination
7.2.5 Fertility Surgeries
7.2.6 Others
7.3 United State of America Infertility Diagnostics Devices Market (2017-2032) by Patient Type
7.3.1 Market Overview
7.3.2 Female
7.3.3 Male
7.4 United State of America Infertility Diagnostics Devices Market (2017-2032) by Type
7.4.1 Market Overview
7.4.2 Sperm Separation Devices
7.4.3 Ovum Aspiration Pumps
7.4.4 Sperm Analyzer Systems
7.4.5 Micromanipulator Systems
7.4.6 Incubators
7.4.7 Cryosystems
7.4.8 Imaging Systems
7.4.9 Microscope
7.4.10 Others
7.5 United State of America Infertility Diagnostics Devices Market (2017-2032) by End User
7.5.1 Market Overview
7.5.2 Hospitals & Surgical Clinics
7.5.3 Cryobanks
7.5.4 Research Institutes
7.5.5 Others
8 Canada Infertility Diagnostics Devices Market (2017-2032)
8.1 Canada Infertility Diagnostics Devices Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Equipment
8.1.3 Media & Consumables
8.1.4 Accessories
8.2 Canada Infertility Diagnostics Devices Market (2017-2032) by Procedure
8.2.1 Market Overview
8.2.2 In Vitro Fertilization
8.2.3 Intracytoplasmic Sperm Injection
8.2.4 Artificial Insemination
8.2.5 Fertility Surgeries
8.2.6 Others
8.3 Canada Infertility Diagnostics Devices Market (2017-2032) by Patient Type
8.3.1 Market Overview
8.3.2 Female
8.3.3 Male
8.4 Canada Infertility Diagnostics Devices Market (2017-2032) by Type
8.4.1 Market Overview
8.4.2 Sperm Separation Devices
8.4.3 Ovum Aspiration Pumps
8.4.4 Sperm Analyzer Systems
8.4.5 Micromanipulator Systems
8.4.6 Incubators
8.4.7 Cryosystems
8.4.8 Imaging Systems
8.4.9 Microscope
8.4.10 Others
8.5 Canada Infertility Diagnostics Devices Market (2017-2032) by End User
8.5.1 Market Overview
8.5.2 Hospitals & Surgical Clinics
8.5.3 Cryobanks
8.5.4 Research Institutes
8.5.5 Others
9 Regulatory Framework
10 Patent Analysis
10.1 Analysis by Type of Patent
10.2 Analysis by Publication year
10.3 Analysis by Issuing Authority
10.4 Analysis by Patent Age
10.5 Analysis by CPC Analysis
10.6 Analysis by Patent Valuation
10.7 Analysis by Key Players
11 Funding and Investment Analysis
11.1 Analysis by Funding Instances
11.2 Analysis by Type of Funding
11.3 Analysis by Funding Amount
11.4 Analysis by Leading Players
11.5 Analysis by Leading Investors
11.6 Analysis by Geography
12 Partnership and Collaborations Analysis
12.1 Analysis by Partnership Instances
12.2 Analysis by Type of Partnership
12.3 Analysis by Leading Players
12.4 Analysis by Geography
13 Supplier Landscape
13.1 Market Share by Top 5 Companies
13.2 Cook Group
13.2.1 Financial Analysis
13.2.2 Product Portfolio
13.2.3 Demographic Reach and Achievements
13.2.4 Mergers and Acquisitions
13.2.5 Certifications
13.3 Vitrolife
13.3.1 Financial Analysis
13.3.2 Product Portfolio
13.3.3 Demographic Reach and Achievements
13.3.4 Mergers and Acquisitions
13.3.5 Certifications
13.4 Thermo Fisher Scientific
13.4.1 Financial Analysis
13.4.2 Product Portfolio
13.4.3 Demographic Reach and Achievements
13.4.4 Mergers and Acquisitions
13.4.5 Certifications
13.5 Hamilton Thorne LTD
13.5.1 Financial Analysis
13.5.2 Product Portfolio
13.5.3 Demographic Reach and Achievements
13.5.4 Mergers and Acquisitions
13.5.5 Certifications
13.6 Esco Micro Pte Ltd
13.6.1 Financial Analysis
13.6.2 Product Portfolio
13.6.3 Demographic Reach and Achievements
13.6.4 Mergers and Acquisitions
13.6.5 Certifications
13.7 Genea Limited
13.7.1 Financial Analysis
13.7.2 Product Portfolio
13.7.3 Demographic Reach and Achievements
13.7.4 Mergers and Acquisitions
13.7.5 Certifications
13.8 IVFtech APS
13.8.1 Financial Analysis
13.8.2 Product Portfolio
13.8.3 Demographic Reach and Achievements
13.8.4 Mergers and Acquisitions
13.8.5 Certifications
13.9 FUJIFILM Irvine Scientific
13.9.1 Financial Analysis
13.9.2 Product Portfolio
13.9.3 Demographic Reach and Achievements
13.9.4 Mergers and Acquisitions
13.9.5 Certifications
13.10 The Baker Company Inc.
13.10.1 Financial Analysis
13.10.2 Product Portfolio
13.10.3 Demographic Reach and Achievements
13.10.4 Mergers and Acquisitions
13.10.5 Certifications
14 North America Infertility Diagnostics Devices Market - Distribution Model (Additional Insight)
14.1 Overview
14.2 Potential Distributors
14.3 Key Parameters for Distribution Partner Assessment
15 Key Opinion Leaders (KOL) Insights (Additional Insight)
16 Company Competitiveness Analysis (Additional Insight)
16.1 Very Small Companies
16.2 Small Companies
16.3 Mid-Sized Companies
16.4 Large Companies
16.5 Very Large Companies
17 Payment Methods (Additional Insight)
17.1 Government Funded
17.2 Private Insurance
17.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security